The Long-Term Care Data Cooperative is a national pool of de-identified nursing-home health records that approved researchers can draw on for studies, including dementia-focused research, and it reaches a resident's information through the facility, not through the family. Participation starts when a nursing home or assisted-living community signs on, which means most caregivers never see a consent form tied to this specific program. For a reader trying to find a Claude or an uncle's record in medical research, that facility-level structure explains both the opportunity and the gap. The data has already supported real dementia work, but the mechanism for a caregiver to ask questions or say no runs through the building, not a portal.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the Cooperative actually does with resident data
- Why your relative's facility, not you, decides on participation
- When does an actual dementia study need your consent?
- Does the participating population look like the national nursing-home population?
- What dementia-specific projects have already used this data?
- How to find out if your relative's facility is involved
- Frequently Asked Questions
What the Cooperative actually does with resident data
The Long-Term Care Data Cooperative, run by the American Health Care Association and National Center for Assisted Living (AHCA/NCAL), collects de-identified electronic health records from participating nursing homes across the country and can link them to Medicare claims data. Approved academic researchers request study-specific extracts for comparative-effectiveness and clinical research, and dementia care is one of the areas those extracts have supported, according to AHCA/NCAL's overview of the Cooperative. The appeal for dementia research is scale.
A single facility's records say little about how a drug interaction or a care protocol plays out across thousands of residents with Alzheimer's disease or a related dementia. Pooling records from many facilities, stripped of identifying details, gives researchers enough volume to detect patterns that a smaller dataset would miss. The Cooperative does not function like a patient registry a family can join directly. It is infrastructure built for researchers, with facilities as the entry point and families largely outside the transaction.
Why your relative's facility, not you, decides on participation
Joining the Cooperative is a decision a nursing home or assisted-living community makes for itself. A facility signs a consortium participation agreement at no cost, and AHCA/NCAL then coordinates with the facility's electronic health record vendor to start transmitting resident data, according to the LTCDC Frequently Asked Questions document. No separate action from residents or their families is required once a facility is already enrolled.
That means a caregiver cannot "opt a facility in" or ask to be excluded from a general enrollment the way they might decline a specific clinical trial. The relevant choice was made by the facility's administration, likely well before any resident currently living there was admitted. This is a structural feature of how the Cooperative was built to scale, not a workaround of any individual consent requirement — because the data entering the pool is de-identified at that stage, not a resident-specific authorization. The consent question reappears, though, when a particular study needs more than de-identified records, which is where the Cooperative's tiered research rules come in.
When does an actual dementia study need your consent?
The Cooperative sorts research uses into consent tiers. "Type 1" projects work only with de-identified data views, which are exempt from Institutional Review Board (IRB) review under HIPAA Safe Harbor standards or a statistical certification that the data cannot be traced back to an individual, according to the LTCDC Categories of Research Catalogue. Most of the comparative-effectiveness work described above falls into this tier, and it proceeds without any resident or family being asked. Studies that need identifiable information, or that involve direct contact with a resident, sit in a different tier.
Those require separate consent from the resident or their proxy, layered on top of the facility's own participation agreement, per the same catalogue. A dementia caregiver managing a relative's affairs as a healthcare proxy would be the person approached if a study of this kind wanted direct interaction with that resident — not for data already flowing through the de-identified pool. Before any outside researcher gets access to Cooperative data at all, the request passes through a research review committee made up mainly of long-term care providers, plus a public-comment period open to participating facilities, according to AHCA/NCAL's program materials. That gives facilities — though not individual families — a vetting role before a study touches their residents' records.
Does the participating population look like the national nursing-home population?
A February 2026 paper in the Journal of the American Geriatrics Society, written by researchers from the IMPACT Collaboratory, compared the Cooperative's 2023 skilled-nursing-facility participants against the full national skilled-nursing population. The study found the enrolled population broadly comparable, with only small, statistically significant demographic and clinical differences, and it noted consistently documented vitals, medication records, glucose readings, and immunizations, according to the IMPACT Collaboratory's summary of the paper. That comparability matters for dementia research specifically, because findings drawn from a skewed subset of facilities would not generalize to residents elsewhere.
Consistent medication and vitals documentation also matters for a condition like dementia, where drug interactions and symptom tracking depend on complete records rather than scattered entries. The Cooperative grew out of pandemic-era data-sharing work and was built with National Institute on Aging support tied to the IMPACT Collaboratory grant. It is explicitly intended to help recruit both providers and residents into embedded pragmatic clinical trials, a trial format used in several dementia-care studies, according to IMPACT Collaboratory background on the project.
What dementia-specific projects have already used this data?
Two projects drawn from the Cooperative's data speak directly to dementia care. One built a drug-drug-interaction risk algorithm covering nursing-home residents with Alzheimer's disease and related dementias.
A second ran an education and deprescribing initiative aimed at reducing unnecessary use of hypoglycemic medications in that same resident population, according to AHCA/NCAL's blog post on the Cooperative's research output. Both projects target a practical problem in dementia care: residents with cognitive impairment often take multiple medications prescribed by different providers, which raises the risk of dangerous interactions or treatments that no longer serve them. A dataset covering many facilities lets researchers flag these patterns at a scale no single nursing home's records could show.
How to find out if your relative's facility is involved
Because the Cooperative has no caregiver-facing consent portal, notification system, or individual opt-out separate from the facility's own participation agreement, the only way to get a direct answer is to ask. No source among AHCA/NCAL's own published materials documents any other channel, according to the LTCDC Frequently Asked Questions document. A caregiver with specific questions has two practical paths: If a study requires direct contact with a resident rather than de-identified records alone, the facility or research team conducting it is the one that must obtain separate consent from the resident or their healthcare proxy — a question worth raising explicitly if a caregiver is ever approached about a dementia-related study tied to a loved one's facility.
- Ask the facility's administration directly whether it has signed the Cooperative's participation agreement, and whether any study currently uses its residents' records.
- Contact AHCA/NCAL's Data and Research office to ask about a specific facility's status or how a named dementia study used the pooled data.
Frequently Asked Questions
Can I ask a nursing home to remove my relative's records from the Cooperative?
No published AHCA/NCAL material describes an individual opt-out; the participation decision belongs to the facility, and a caregiver's direct option is to ask the facility about its own agreement.
Does every dementia study using this data require my consent?
No. Studies using only de-identified data under the Cooperative's "Type 1" category are exempt from separate consent; only studies needing identifiable data or direct resident contact require consent from the resident or proxy.
Who reviews a request to study my relative's facility's data?
A research review committee made up mainly of long-term care providers evaluates each outside request, alongside a public-comment period among participating facilities, before access is granted.
You Might Also Like
- UAS-CLEAR Dementia Care Research Data Priorities in 2026: Research Participation Questions for Family Caregivers
- NHATS and NSOC Dementia Care Data Priorities in 2026: Research Participation Questions for Family Caregivers
- Electronic Health Records for Dementia Care Research in 2026: Research Participation Questions for Family Caregivers
